Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2066434rdf:typepubmed:Citationlld:pubmed
pubmed-article:2066434lifeskim:mentionsumls-concept:C0023364lld:lifeskim
pubmed-article:2066434lifeskim:mentionsumls-concept:C0162596lld:lifeskim
pubmed-article:2066434pubmed:issue6lld:pubmed
pubmed-article:2066434pubmed:dateCreated1991-8-15lld:pubmed
pubmed-article:2066434pubmed:abstractTextThe clinical course and serology of 16 cases of leptospirosis in an area with an unusually high endemic infection rate were studied to gain further insight into the pathology of the secondary immune phase that is typical of the disease. IgG anticardiolipin antibody concentrations were measured by immunoassay and found to be increased in eight serologically confirmed cases with severe complicated disease, compared with eight patients with relatively uncomplicated leptospirosis who had IgG anticardiolipin concentrations within the control reference range. This previously unreported association suggests that leptospira may induce vascular endothelial injury in severe cases and expose crypt antigens or induce conformational change of cell surface phospholipids. Leptospirosis may provide a model for an infective origin of some cases of the antiphospholipid syndrome.lld:pubmed
pubmed-article:2066434pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:languageenglld:pubmed
pubmed-article:2066434pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2066434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2066434pubmed:statusMEDLINElld:pubmed
pubmed-article:2066434pubmed:monthJunlld:pubmed
pubmed-article:2066434pubmed:issn0021-9746lld:pubmed
pubmed-article:2066434pubmed:authorpubmed-author:WaiteMMlld:pubmed
pubmed-article:2066434pubmed:authorpubmed-author:PinkHHlld:pubmed
pubmed-article:2066434pubmed:authorpubmed-author:PalmerM FMFlld:pubmed
pubmed-article:2066434pubmed:authorpubmed-author:RugmanF PFPlld:pubmed
pubmed-article:2066434pubmed:authorpubmed-author:HayC RCRlld:pubmed
pubmed-article:2066434pubmed:issnTypePrintlld:pubmed
pubmed-article:2066434pubmed:volume44lld:pubmed
pubmed-article:2066434pubmed:ownerNLMlld:pubmed
pubmed-article:2066434pubmed:authorsCompleteYlld:pubmed
pubmed-article:2066434pubmed:pagination517-9lld:pubmed
pubmed-article:2066434pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2066434pubmed:meshHeadingpubmed-meshheading:2066434-...lld:pubmed
pubmed-article:2066434pubmed:meshHeadingpubmed-meshheading:2066434-...lld:pubmed
pubmed-article:2066434pubmed:meshHeadingpubmed-meshheading:2066434-...lld:pubmed
pubmed-article:2066434pubmed:meshHeadingpubmed-meshheading:2066434-...lld:pubmed
pubmed-article:2066434pubmed:meshHeadingpubmed-meshheading:2066434-...lld:pubmed
pubmed-article:2066434pubmed:year1991lld:pubmed
pubmed-article:2066434pubmed:articleTitleAnticardiolipin antibodies in leptospirosis.lld:pubmed
pubmed-article:2066434pubmed:affiliationUniversity Department of Haematology, Royal Liverpool Hospital.lld:pubmed
pubmed-article:2066434pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2066434lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2066434lld:pubmed